AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM)

CUSIP: 02290A102

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / SPONSORED ADS
Total 13F shares
49,416,240
Share change
+1,494,936
Total reported value
$568,286,721
Put/Call ratio
34%
Price per share
$11.50
Number of holders
44
Value change
-$2,289,975
Number of buys
32
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 02290A102?
CUSIP 02290A102 identifies AMAM - AMBRX BIOPHARMA INC - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) as of Q3 2023

As of 30 Sep 2023, AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,416,240 shares. The largest 10 holders included Darwin Global Management, Ltd., Cormorant Asset Management, LP, D. E. Shaw & Co., Inc., COMMODORE CAPITAL LP, Paradigm Biocapital Advisors LP, FEDERATED HERMES, INC., VR Adviser, LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, and CITADEL ADVISORS LLC. This page lists 44 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.